{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:26:38Z","timestamp":1747196798422,"version":"3.40.5"},"reference-count":57,"publisher":"Veterinary World","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet World"],"abstract":"<jats:p>Background and Aim: The morbidity and mortality of Shigella infections remain a global challenge. Epitope-based vaccine development is an emerging strategy to prevent bacterial invasion. This study aimed to identify the ability of the 49.8 kDa pili subunit adhesin protein epitope of Shigella flexneri to induce an intestinal immune response in mice. Materials and Methods: Thirty adult male Balb\/c mice were divided into a control group, cholera toxin B subunit (CTB) group, CTB+QSSTGTNSQSDLDS (pep_1) group, CTB+DTTITKAETKTVTKNQVVDTPVTTDAAK (pep_2) group, and CTB+ ATLGATLNRLDFNVNNK (pep_3). We performed immunization by orally administering 50 \u03bcg of antigen and 50 \u03bcl of adjuvant once a week over 4 weeks. We assessed the cellular immune response by quantifying T helper 2 (Th2) and Th17 using flow cytometry. In addition, we assessed the humoral immune response by quantifying interleukin (IL-4), IL-17, secretory immunoglobulin A (sIgA), and \u03b2-defensin using enzyme-linked immunoassay. Statistical analysis was performed using one-way analysis of variance and Kruskal\u2013Wallis test. Results: Peptide oral immunization increases the cellular immune response as reflected by the increase of Th2 (p=0.019) and Th17 (p=0.004) cell counts, particularly in the CTB_pep_1 group. Humoral immune response activation was demonstrated by increased IL-4 levels, especially in the CTB+pep_3 group (p=0.000). The IL-17 level was increased significantly in the CTB+pep_1 group (p=0.042). The mucosal immune response was demonstrated by the sIgA levels increase in the CTB+pep_3 group (p=0.042) and the \u03b2-defensin protein levels (p=0.000). Conclusion: All selected peptides activated the cellular and humoral immune responses in the intestine of mice. Further studies are necessary to optimize antigen delivery and evaluate whether the neutralizing properties of these peptides allow them to prevent bacterial infection.<\/jats:p>","DOI":"10.14202\/vetworld.2022.281-287","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T11:12:06Z","timestamp":1644577926000},"page":"281-287","source":"Crossref","is-referenced-by-count":7,"title":["Shigella flexneri vaccine development: Oral administration of peptides derived from the 49.8 kDa pili protein subunit activates the intestinal immune response in mice"],"prefix":"10.14202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7676-2827","authenticated-orcid":false,"given":"Khoirul","family":"Anam","sequence":"first","affiliation":[{"name":"Doctoral Program in Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia; Study Program of Medical Laboratory Technology, Institute of Health and Science Technology Wiyata Husada, Samarinda, Indonesia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2062-5740","authenticated-orcid":false,"given":"Agustina Tri","family":"Endharti","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-4657","authenticated-orcid":false,"given":"Sri","family":"Poeranto","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6568-3584","authenticated-orcid":false,"given":"Hidayat","family":"Sujuti","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-4573","authenticated-orcid":false,"given":"Dwi Yuni Nur","family":"Hidayati","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-4806","authenticated-orcid":false,"given":"Sumarno Reto","family":"Prawiro","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5308","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"ref0","unstructured":"Niyogi, S.K. (2005) Shigellosis. J. Microbiol., 43(2): 133-143."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Al-Moyed, K.A., Harmal, N.S., Al-Harasy, A.H. and Al-Shamahy, H.A. (2006) Increasing single and multi-antibiotic resistance in Shigella species isolated from shigellosis patients in Sana\u2019a, Yemen. Saudi Med. J., 27(8): 1157-1160.","DOI":"10.4103\/0256-4947.51457"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Mani, S., Wierzba, T. and Walker, R.I. (2016) Status of vaccine research and development for Shigella. Vaccine, 34(26): 2887-2894.","DOI":"10.1016\/j.vaccine.2016.02.075"},{"key":"ref3","unstructured":"Nikfar, R., Shamsizadeh, A., Darbor, M., Khaghani, S. and Moghaddam, M. (2017) A Study of prevalence of Shigella species and antimicrobial resistance patterns in paediatric medical center, Ahvaz, Iran. Iran. J. Microbiol., 9(5): 277-282."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Gaurav, A., Singh, S.P., Gill, J.P.S., Kumar, R. and Kumar, D. (2013) Isolation and identification of Shigella spp. from human fecal samples collected from Pantnagar, India. Vet. World, 6(7): 376-379.","DOI":"10.5455\/vetworld.2013.376-379"},{"key":"ref5","unstructured":"Khaghani, S., Shamsizadeh, A., Nikfar, R. and Hesami, A. (2014) Shigella flexneri: A three-year antimicrobial resistance monitoring of isolates in a Children Hospital, Ahvaz, Iran. Iran. J. Microbiol., 6(4): 225-229."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Sumarno, R.P., Avanita, A.S., Winarsih, S., Hidayat, S. and Nurhidayati, D.Y. (2015) Haemagglutination of Shigella dysenteriae subunit pili protein with and anti-haemagglutination of Shigella dysenteriae subunit pili protein as a molecule adhesin in mouse enterocytes. Afr. J. Med. Res., 9(11): 781-787.","DOI":"10.5897\/ajmr2014.7273"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Agustina, W., Fitri, L.E., Raras, T.Y.R.., Siswanto, B. and Prawiro, S.R. (2012) Antibody protein hemagglutinin subunit pili with MW 49,8 kDa Shigella dysentriae can inhibit Shigella dysentriae adhesin on mice enterocyte. IOSR J. Pharm., 2(5): 13-20.","DOI":"10.9790\/3013-25501320"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Anam, K., Nurdiana., Herowati, T.E., Sujuti, H. and Sumarno, R.P. (2016) Cross immunity among pili sub-unit hemagglutinin and pili sub-unit anti hemagglutinin proteins of Shigella spp. Int. J. Pharm Pharm. Res. Human, 7(2): 19-30.","DOI":"10.11594\/jtls.07.01.01"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Faisal, R., Sumarno. and Handono, K. (2010) Sumbawa fermented horse milk as immunostimulants for 37.8 kDa V. cholerae vaccine. J. Braw Med., 26(1): 225-230.","DOI":"10.21776\/ub.jkb.2010.026.02.2"},{"key":"ref10","unstructured":"Setyorini, A., Utami, Y.D., Wijayanto, E., Winarsih, S., Noorhamdani, A.S. and Prawiro, S.R. (2013) Protective of adhesin molecules pili 49,8 kDa Shigella dysenteriae conjugated with ISCOM against bacterial colonization and colonic epithelial cells damage in mice. Int. J. Trop. Med., 8(1): 19-26."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Yang, Y., Liu, K., Chen, Y., Gong, Y. and Liang, Y. (2019) Indoleamine 2,3-dioxygenase (IDO) regulates Th17\/Treg immunity in experimental IgA nephropathy. Folia Biol. (Praha), 65(2): 101-108.","DOI":"10.14712\/fb2019065020101"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Yanagita, M., Hiroi, T., Kitagaki, N., Hamada, S., Ito, H., Shimauchi, H., Murakami, S., Okada, H. and Kiyono, H. (1999) Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: Fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J. Immunol., 162(6): 3559-3565.","DOI":"10.4049\/jimmunol.162.6.3559"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Dong, C. (2008) Th17 cells in development: An updated view of their molecular identity and genetic programming. Nat. Rev. Immunol., 8(5): 337-348.","DOI":"10.1038\/nri2295"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Sellge, G., Magalhaes, J.G., Konradt, C., Fritz, J.H., Salgado-Pabon, W., Eberl, G., Bandeira, A., Di Santo, J.P., Sansonetti, P.J. and Phalipon, A. (2010) Th17 cells are the dominant T Cell subtype primed by S. flexneri mediating protective immunity. J. Immunol., 184(4): 2076-2085.","DOI":"10.4049\/jimmunol.0900978"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Cao, A.T., Suxio, Y., Bin, G., Co, E. and Yingzi, C. (2012) Th17 Cells Upregulate Polymeric Ig receptor and intestinal homeostasis. J. Immunol., 189(9): 4666-4673.","DOI":"10.4049\/jimmunol.1200955"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Shin, D.M. and Kyeong Jo, E. (2011) Antimicrobial peptides in innate immunity against mycobacteria. Immune. Network, 11(5): 245-252.","DOI":"10.4110\/in.2011.11.5.245"},{"key":"ref17","unstructured":"Utami, W.J., Wiwik, A., Winarsih, S., Sujuti, H. and Sumarno. (2017) The fermented horse milk can as an immune stimulant pili sub units of S. flexneri protein conjugated with CTB in mice. Acta Sci. Pharm. Sci., 1(2017): 30-37."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Walker, R.I., Wierzba, T.F., Mani, S. and Bourgeois, A.L (2017) Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE conference. Vaccine, 35(49 Pt A): 6775-6782.","DOI":"10.1016\/j.vaccine.2017.09.045"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Suharsono, H., Muttaqin, Z., Tenaya, I.W.M., Agustina, K.K. and Prawiro, S.R. (2019) Antigen of 49.6-kDa subunit pili protein of Helicobacter pylori as a potential biomarker for early and rapid detection of H. pylori infection. Vet. World, 12(6): 769-773.","DOI":"10.14202\/vetworld.2019.769-773"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Pore, D., Mahata, N., Pal, A. and Chakrabarti, M.K. (2011) Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model. PLoS One, 6(7): e22663.","DOI":"10.1371\/journal.pone.0022663"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Sharma, D., Patel, S., Padh, H. and Desai, P. (2016) Immunoinformatic identification of potential epitopes against shigellosis. Int. J. Pept. Res. Ther., 22(4): 481-495.","DOI":"10.1007\/s10989-016-9528-6"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Patronov, A. and Doytchinova, I. (2013) T-cell epitope vaccine design by immunoinformatics. Open Biol., 3(1): 120139.","DOI":"10.1098\/rsob.120139"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Nezafata, N., Karimia, Z., Eslamia, M., Mohkama, M., Zandiana, S. and Ghasemia, Y. (2016) Designing an efficient multiepitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches. Comput. Biol. Chem., 62: 82-95.","DOI":"10.1016\/j.compbiolchem.2016.04.006"},{"key":"ref24","unstructured":"Ghazi, F.M.P. and Gargari, S.L.M. (2017) Synthetic peptides mimicking lipopolysaccharide as a potential vaccine candidate against Vibrio cholerae serogroup O1. Iran. J. Microbiol., 9(4): 244-250."},{"key":"ref25","unstructured":"Sumarno., Anam, K., Utami, Y.W., Nurhidayati, Y., Winarsih, S. and Sujuti, H. (2019) The response of anti-peptide serum antibodies ATLGATLNRLDFNVNNK derived from S. flexneri protein sub-unit pili toward activity the hemagglutination and protection from leaking solution enterocyte in mice. Arch. Immunol. Allergy, 2(2): 49-57."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Kurnianingsih, N., Ratnawati, R., Nazwar, T.A., Ali, M. and Fatchiyah, F. (2020) The behavioral effect of anthocyanin from purple sweet potatoes on prenatally stressed offspring mice. Syst. Rev. Pharm., 11(10): 482-490.","DOI":"10.5455\/medarh.2021.75.94-100"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Guli, M., Illiandri, O., Winarsih, S., Barlianto, W. and Prawiro, S.R. (2021) Immunoenhancing effect of Lactobacillus reuteri on immunized mice intestine using cholerae toxin subtype B. J. Adv. Pharm. Edu. Res., 11(1): 11-17.","DOI":"10.51847\/qguefse"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Bringans, S., Soren, E., Tulene, K., Gopalakrishnakone, P., Andreja, L., Robert, L. and Lipscombe, R. (2008) Proteomic analysis of the venom of Heterometrus longimanus (Asian black scorpion) Scott. Proteomics, 8(5): 1081-1096.","DOI":"10.1002\/pmic.200700948"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Prawiro, S.R., Anam, K., Prabowo, B., Bramanthi, R., Fitrianingsih, A.A., Hidayati, . D.Y.N., Imawati, S., Fitria, E. and Winarsih, S. (2021) Generating the responses immune with honey, Saussurea costus, and Nigella sativa in cellular and humoral may resolve COVID-19? Syst. Rev. Pharm., 12(1): 1588-1593.","DOI":"10.21010\/ajid.v15i2s.3"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Schroeder, G.N. and Hilbi, H. (2008) Molecular pathogenesis of Shigella spp.: Controlling host cell signaling, invasion, and death by Type III secretion. Clin. Microbiol. Rev., 21(1): 134-156.","DOI":"10.1128\/cmr.00032-07"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Killackey, S.A., Sorbara, M.T. and Girardin, S.E. (2016) Cellular aspects of Shigella pathogenesis: Focus on the manipulation of host cell processes. Front. Cell. Infect. Microbiol., 6(38): 1-11.","DOI":"10.3389\/fcimb.2016.00038"},{"key":"ref32","unstructured":"Salyers, A.A. and Whitt, D.D. (2002) Bacterial Pathogenesis: A Molecular Approach. 2nd ed. American Society for Microbiology Press, Washington DC."},{"key":"ref33","unstructured":"Nezet, V. and Esko, J.D. (2009) Bacterial and Viral Infections, Mechanism of Colonization and Invasion, Essential of Gynecology. 2nd ed. La-Jolla, California."},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Rasolofo-Razanamparany, V., Cassel-Beraud, A.M., Roux, J., Sansonetti, P.J. and Phalipon, A. (2001) predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity. Infect. Immun., 69(9): 5230-5234.","DOI":"10.1128\/iai.69.9.5230-5234.2001"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Leung, S., Liu, X., Fang, L., Chen, X., Guo, T. and Zhang, J. (2010) The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease. Cell. Mol. Immunol., 7(3): 182-189.","DOI":"10.1038\/cmi.2010.22"},{"key":"ref36","unstructured":"Abbas, A.K., Lichtman, A.H. and Pillai, S. (2015) Cellular and Molecular Immunology. 8th ed. Elsevier-Saunders, United States."},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Kaetzel, C.S. (2007) Mucosal Immune Defense: Immunoglobulin A. Springer, New York.","DOI":"10.1007\/978-0-387-72232-0"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Sperandio, B., Regnault, B., Guo, J., Zhang, Z., Stanley, S.L.J., Sansonetti, P.J. and P\u00e9dron, T. (2008) Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J. Exp. Med., 205(5): 1121-1132.","DOI":"10.1084\/jem.20071698"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Dhanda, S.K., Gupta, S., Vir, P. and Raghava, G.P.S. (2013) Prediction of IL-4 Inducing Peptides. Clin. Dev. Immunol., 2013(Article ID 263952): 1-9","DOI":"10.1155\/2013\/263952"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Chitradevi, S.T.S., Kaur, G., Uppalapati, S., Yadav, A., Singh, D. and Bansal, A. (2015) Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection. Cell. Mol. Immunol., 12(6): 757-767.","DOI":"10.1038\/cmi.2014.86"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Lee, S.J., McLachlan, J.B., Kurtz, J.R., Fan, D., Winter, S.E., B\u00e4umler, A.J, Jenkins, M.K. and McSorley, S.J. (2012) Temporal expression of bacterial proteins instruct host CD4 T cell expansion and Th17 development. PLoS Pathog., 8(1): e1002499.","DOI":"10.1371\/journal.ppat.1002499"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Kurtz, J.R., Petersen, H.E., Frederick, D.R., Morici, L.A. and McLachlan, J.B. (2014) Vaccination with a single CD4 T cell peptide epitope from a Salmonella Type III-secreted effector protein provides protection against lethal infection. Infect. Immun., 82(6): 2424-2433.","DOI":"10.1128\/iai.00052-14"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Brown, M.A. and Hural, J. (1997) Functions of IL-4 and control of its expression. Crit. Rev. Immunol., 17(1): 1-32.","DOI":"10.1615\/critrevimmunol.v17.i1.10"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Padh, H., Yagnik, B., Sharma, D. and Desai, P. (2021) EpiMix based novel vaccine candidate for Shigella: Evidence of prophylactic immunity in Balb\/c Mice. Int. J. Pept. Res. Ther., p1-16, doi: 10.1007\/s10989-020-10153-0.","DOI":"10.1007\/s10989-020-10153-0"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Le\u00f3n, Y., Zapata, L., Molina, R.E., Okanovic, G., G\u00f3mez, L.A., Daza-Castro, C., Flores-Concha, M., Reyes, J.L. and O\u00f1ate, A.A. (2020) Intranasal immunization of mice with multiepitope chimeric vaccine candidate based on conserved autotransporters SigA, Pic and Sap, confers protection against Shigella flexneri. Vaccines, 8(4): 563.","DOI":"10.3390\/vaccines8040563"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Jennison, A.V. and Verma, N.K. (2004) Shigella flexneri infection: Pathogenesis and vaccine development. FEMS. Microbiol. Rev., 28(1): 43-58.","DOI":"10.1016\/j.femsre.2003.07.002"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Pasetti, M.F., Venkatesan, M.M. and Barry, E.M. (2020) Chapter 30-oral Shigella vaccines. In: Kiyono, H. and Pascual, D.W., editors. Mucosal Vaccines. 2nd ed. Academic Press, Cambridge, MA, USA. p515-536.","DOI":"10.1016\/b978-0-12-811924-2.00030-4"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., Sudo, K., Nakae, S., Sasakawa, C. and Iwakura, Y. (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity, 30(1): 108-119.","DOI":"10.1016\/j.immuni.2008.11.009"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Curtis, M.M. and Way, S.S. (2009) Interleukin-17 in host defense against bacterial, mycobacterial and fungal pathogens. Immunology, 126(2): 177-185.","DOI":"10.1111\/j.1365-2567.2008.03017.x"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Martinez-Becerra, F.J., Scobey, M., Harrison, K., Choudhari, S.P., Quick, A.M., Joshi, S.B., Middaugh, C.R. and Picking, W.L. (2013) Parenteral immunization with IpaB\/IpaD protects mice against lethal pulmonary infection by Shigella. Vaccine, 31(24): 2667-2672.","DOI":"10.1016\/j.vaccine.2013.04.012"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Blaschitz, C. and Raffatelu, M. (2010) Th 17 cytokines and the gut mucosal barrier. J. Clin. Immunol., 30(2): 196-203.","DOI":"10.1007\/s10875-010-9368-7"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Agerberth, B., Bergman, P. and Gudmundsson, G.H. (2013) Helping the host: Induction of antimicrobial peptides as a novel therapeutic strategy against infections. In: Antimicrobial Peptides and Innate Immunity. Springer, Basel, Switzerland. p359-375.","DOI":"10.1007\/978-3-0348-0541-4_14"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Cobo, E.R. and Chadee, K. (2013) Antimicrobial human \u03b2-defensins in the colon and their role in infectious and non-infectious diseases. Pathogens, 2(1): 177-192.","DOI":"10.3390\/pathogens2010177"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Fusco, A., Savio, V., Cammarota, M., Alfano, A., Schiraldi, C. and Donnarumma, G. (2017) Beta-defensin-2 and beta-defensin-3 reduce intestinal damage caused by Salmonella typhimurium modulating the expression of cytokines and enhancing the probiotic activity of Enterococcus faecium. J. Immunol. Res., 2017(Article ID 6976935): 1-9.","DOI":"10.1155\/2017\/6976935"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Wang, S., Huiqin L., Xinyi, Z. and Feng, Q. (2015) Intranasal and oral vaccination with protein-based antigens: Advantages, challenges, and formulation strategies. Protein Cell, 6(7): 480-503.","DOI":"10.1007\/s13238-015-0164-2"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Coria, L.M., Gabriela, S.R., Francisco, F.G., Mariana, C.F., Laura, B., Karina, A. and Cassataro, J. (2019) Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier. J. Control. Release., 293 : 158-171.","DOI":"10.1016\/j.jconrel.2018.11.025"}],"container-title":["Veterinary World"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/February-2022\/7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/February-2022\/7.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/February-2022\/7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T09:44:53Z","timestamp":1726652693000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/February-2022\/7.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":57,"URL":"https:\/\/doi.org\/10.14202\/vetworld.2022.281-287","relation":{},"ISSN":["2231-0916","0972-8988"],"issn-type":[{"type":"electronic","value":"2231-0916"},{"type":"print","value":"0972-8988"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}